KELLI MEEKS: Open Payments
NPI 1255172870 · DUNNELLON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,067 in 113 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,067
Food & beverage: $2,067
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $383 |
| Novo Nordisk Inc | 24 | $346 |
| GlaxoSmithKline, LLC. | 18 | $278 |
| ABBVIE INC. | 11 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $106 |
| Astellas Pharma US Inc | 5 | $99 |
| Lilly USA, LLC | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| Paratek Pharmaceuticals, Inc. | 3 | $58 |
Products named: TRELEGY ELLIPTA, JARDIANCE, Ozempic, Wegovy, VRAYLAR, AIRSUPRA, Kerendia, Veozah.
Industry payments across FL — which companies pay providers there.
